The five posters will cover clinical data on the company’s DuraSite 2 platform and treatment of various ophthalmologic conditions.
The ARVO 2013 meeting will be held May 5 to 9 in Seattle.
More Articles on Ophthalmology:
FDA Grants R-Tech Ueno IND Approval for Dry Eye Treatment
Pharm-Olam, InSite Vision Complete Phase 3 Clinical Study
Glaucoma Management Lens to be Presented at ARVO 2013
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
